Insider: Cheng Andrew President and CEO - Akero Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 473,902 | 0 | 473,902 |
| Value | $22,268,654.98 | $0.00 | $22,268,654.98 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/11/2025 | DDS | 1,796 | Direct | COM | $43.02 | $77,263.92 | 473,902 |
| 09/10/2025 | DDS | 22,525 | Direct | COM | $42.99 | $968,439.85 | 483,173 |
| 09/10/2025 | DDS | 7,317 | Direct | COM | $44.00 | $321,911.42 | 475,856 |
| 09/10/2025 | DDS | 158 | Direct | COM | $44.62 | $7,049.96 | 475,698 |
| 08/11/2025 | DDS | 10,795 | Direct | COM | $48.07 | $518,915.65 | 509,962 |
| 08/11/2025 | DDS | 18,805 | Direct | COM | $48.87 | $918,906.33 | 491,157 |
| 08/11/2025 | DDS | 400 | Direct | COM | $49.44 | $19,774.00 | 490,757 |
| 07/10/2025 | DDS | 14,686 | Direct | COM | $50.57 | $742,671.02 | 536,071 |
| 07/10/2025 | DDS | 15,314 | Direct | COM | $51.73 | $792,223.85 | 520,757 |
| 06/18/2025 | DDS | 6,620 | Direct | COM | $54.84 | $363,040.80 | 549,867 |
| 06/10/2025 | DDS | 15,158 | Direct | COM | $54.35 | $823,882.77 | 564,324 |
| 06/10/2025 | DDS | 14,842 | Direct | COM | $53.76 | $797,905.92 | 579,482 |
| 06/10/2025 | DDS | 7,837 | Direct | COM | $53.99 | $423,150.98 | 556,487 |
| 05/12/2025 | DDS | 7,200 | Direct | COM | $41.00 | $295,200.00 | 617,124 |
| 05/12/2025 | DDS | 22,800 | Direct | COM | $41.63 | $949,255.20 | 594,324 |
| 04/10/2025 | DDS | 30,000 | Direct | COM | $35.23 | $1,056,780.00 | 624,324 |
| 03/12/2025 | DDS | 1,738 | Direct | COM | $44.88 | $78,001.44 | 654,324 |
| 03/10/2025 | DDS | 28,784 | Direct | COM | $41.75 | $1,201,616.86 | 657,278 |
| 03/10/2025 | DDS | 1,216 | Direct | COM | $42.31 | $51,452.61 | 656,062 |
| 02/10/2025 | DDS | 12,640 | Direct | COM | $51.75 | $654,145.28 | 703,422 |
| 02/10/2025 | DDS | 6,439 | Direct | COM | $52.91 | $340,674.61 | 696,983 |
| 02/10/2025 | DDS | 9,972 | Direct | COM | $53.67 | $535,157.35 | 687,011 |
| 02/10/2025 | DDS | 200 | Direct | COM | $55.81 | $11,162.00 | 686,062 |
| 02/10/2025 | DDS | 749 | Direct | COM | $54.55 | $40,854.95 | 686,262 |
| 01/27/2025 | DDS | 24,242 | Direct | COM | $54.56 | $1,322,643.52 | 721,820 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research